Marlin Global (MLN)•FY21•Released 24 August 2021MLN FY21 NPAT tripled to NZ$69.2m but operating cash swung NZ$23.3m negativeInvestment-company earnings were driven by portfolio revaluation gains, not cash receipts, leaving reported profit and cash flow moving in...Published 22 April 2026Read briefing→
Barramundi (BRM)•FY21•Released 24 August 2021BRM FY21 NPAT quadruples to $52.3m on portfolio gainsA 265% revenue jump and 318% NPAT rise lifted equity 31%, but most of the result sits in investment revaluations rather than cash.Published 22 April 2026Read briefing→
Australian Foundation Investment Company (AFI)•FY21•Released 26 July 2021AFI FY21: NPAT held at -2.2% but operating cash flow slid 29.8%Portfolio-driven equity rose 21.1% to $7.56bn and the 14cps final was held flat, but dividend income and cash receipts both weakened materially.Published 22 April 2026Read briefing→
Templeton Emerging Markets Investment Trust Plc (TEM)•FY21•Released 8 June 2021Portfolio revaluation flipped PBT NZ$272.7m positive as dividend income fell...FY21 headline earnings were driven by investment gains, not income: underlying revenue shrank while the H2 portfolio move reversed sharply.Published 22 April 2026Read briefing→
Kingfish (KFL)•FY21•Released 27 May 2021KFL swings to NZ$142.7m NPAT on portfolio gains as cash outflow widensListed-investment vehicle rides equity-market recovery from a NZ$1.7m FY20 base, but operating cash outflow deepens to NZ$48.3m.Published 22 April 2026Read briefing→